A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer
Conference Paper
- Overview
- Additional Document Info
- View All
Overview
publication date
- September 1, 2017
has subject area
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal